AbbVie Inc. (ABBV) vs Bank of America Corporation (BAC)

AbbVie Inc. is a pharmaceutical company with significant exposure to immunology through Humira, Skyrizi, and Rinvoq, and to oncology through Imbruvica and Venclexta. The company was spun off from Abbott in early 2013. Its 2020 acquisition of Allergan expanded its portfolio with additional products in aesthetics, including Botox. In 2024, AbbVie further strengthened its business through the acquisitions of Cerevel in neuroscience and ImmunoGen in oncology.

Bank of America Corporation is one of the largest U.S. financial institutions, with a $3.5 trillion balance sheet and the second-largest deposit market share in the country, underscoring its central role in the American economy. The company has preserved a strong position among domestic middle-market and retail customers while also maintaining a significant international presence, supported by the world’s fourth-largest trading operation and an investment banking business that consistently ranks among the top four in global league tables. Bank of America operates through four main segments: consumer banking, global wealth and investment management, global banking, and global markets.